Tuesday, 3 April 2012

Apex Healthcare versus Dutch Lady (A Comparative Study)


3.4.2012 5.3.2012
Apex Healthcare Dutch Lady
Income Statement
31/12/2011 31/12/2011
RM (m) RM (m)
Revenue 366.00 810.65
Gross Profit 95.14 304.47
Operating Profit  - 139.372
Financing costs -0.288 -0.919
PBT 35.849 141.553
PAT 28.468 108.082
EPS (basic) sen 29.96 168.88
EPS (diluted) sen 29.96
Balance Sheet
NCA 85.596 74.048
CA 202.303 324.465
Total Assets 287.899 398.513
Total Equity 212.212 259.154
NCL 8.737 4.051
CL 66.95 135.308
Total Liabilities 75.687 139.359
Total Eq + Liab 287.899 398.513
Net assets per share 2.120 4.05
Cash & Eq 22.802 193.143
LT Borrowings 1.345 0
ST Borrowings 2.267 0
Net Cash 19.19 193.143
Inventories 43.098 93.448
Trade receivables 86.158 36.713
Trade payables 63.665 121.831
Quick Ratio 2.38 1.71
Current Ratio 3.02 2.40
Cash flow statement
PBT 35.849 141.553
OPBCWC 42.941
Cash from Operations 39.476 188.290
Net CFO 32.650 161.940
CFI -15.866 -7.135
CFF -16.979 -47.319
Capex -13.251 -10.882
FCF 19.399 151.058
Dividends paid -11.363 -46.400
DPS (sen) 12.12 72.5
No of ord shares (m)
basic 93.717 64
diluted
Financial Ratios
Gross Profit Margin 25.99% 37.56%
Net Profit Margin 7.78% 13.33%
Asset Turnover 1.27 2.03
Financial Leverage 1.36 1.54
ROA 9.89% 27.12%
ROC 14.75% 163.73%
ROE 13.41% 41.71%
Valuation 3.4.2012 5.3.2012
Price  2.92 29.5
Market cap (m) 273.65 1888.00
P/E 9.61 17.47
P/BV 1.29 7.29
P/FCF 14.11 12.50
P/Div 24.08 40.69
DPO ratio 0.40 0.43
EY 10.40% 5.72%
FCF/P 7.09% 8.00%
DY 4.15% 2.46%

No comments: